Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
Sponsor: Novartis Pharmaceuticals
Atopic Dermatitis
United States, Argentina, Canada, China, Czechia +12 more
Sponsor: Akero Therapeutics, Inc
NASH - Nonalcoholic Steatohepatitis · MASH - Metabolic Dysfunction-Associated Steatohepatitis
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: ModernaTX, Inc.
Respiratory Syncytial Virus (RSV) · Human Metapneuomovirus (hMPV)
Canada, United Kingdom
Sponsor: W.L.Gore & Associates
Vascular Disease · Dissection · Dissection Aortic Aneurysm · Dissection of Aorta
United States, Denmark, France, Germany, Greece +5 more
- Closed-loop tES-non-invasive StimulationNot Yet Recruiting
Sponsor: University of Nottingham
Closed-loop Brain Stimulation
United Kingdom
Sponsor: BeOne Medicines
Mantle Cell Lymphoma · B Cell Lymphoma
United States, Argentina, Australia, Austria, Brazil +12 more
- Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular AtrophyRecruiting
Sponsor: Alcyone Therapeutics, Inc
Spinal Muscular Atrophy · Spine Deformity · Scoliosis
United States, Germany, Poland, Spain, United Kingdom
Sponsor: Boehringer Ingelheim
Solid Tumours
United States, Australia, Belgium, Canada, China +11 more
- MiCLASP Post Market Clinical Follow-Up (PMCF) StudyActive Not Recruiting
Sponsor: Edwards Lifesciences
Mitral Regurgitation · Mitral Insufficiency
Austria, Germany, Greece, Italy, Netherlands +4 more
Sponsor: Covaci Brindusa
Well Being · Nutrition Efficiency
United Kingdom
Sponsor: King's College London
Major Depressive Disorder · Inflammatory Bowel Diseases
United Kingdom
Sponsor: AstraZeneca
Bronchiectasis With Pseudomonas Aeruginosa Colonization
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: Royal Holloway University
Primary Headaches (Includes Migraines, Tension, Cluster Headaches)
United Kingdom
- Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth SpectrumActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
PIK3CA-related Overgrowth Spectrum (PROS)
United States, Canada, China, France, Germany +7 more
- Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant SystemCompleted
Sponsor: ZimVie
Partial Edentulism · Tooth Disease
Belgium, France, Germany, United Kingdom
Sponsor: Regeneron Pharmaceuticals
Relapsed/Refractory Systemic Light Chain Amyloidosis
United States, Greece, South Korea, Spain, Taiwan +1 more
Sponsor: Boehringer Ingelheim
Fibrosing Interstitial Lung Disease
United States, Argentina, Australia, Belgium, Brazil +17 more
Sponsor: Dianthus Therapeutics
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Healthy Volunteers
United Kingdom
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +29 more
Sponsor: Novo Nordisk A/S
Obesity · Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +22 more
Sponsor: Hansa Biopharma AB
Kidney Transplantation in Highly Sensitized Patients
Finland, France, Spain, Sweden, United Kingdom
- The SPARK-PMDD StudyNot Yet Recruiting
Sponsor: King's College London
Premenstrual Dysphoric Disorder · PMDD · Premenstrual Dysphoric Disorder ( PMDD) · Premenstrual Dysphoric Disorder (PMDD)
United Kingdom
- Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 DiabetesEnrolling By Invitation
Sponsor: Salah Snouda
Type 2 Diabetes Mellitus (T2DM) · Insulin Resistance · Metabolic Syndrome
United Kingdom
Sponsor: University of Birmingham
Type 2 Diabetes
United Kingdom